ABBV - AbbVie Inc.
Close
174.83
0.250 0.143%
Share volume: 105,851
Last Updated: Fri 10 Jan 2025 08:30:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.49%
PREVIOUS CLOSE
CHG
CHG%
$174.58
0.25
0.14%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-03 | 2023-08-07 | 2023-11-06 | 2024-11-04 | 2024-05-03 | 2024-08-07 | 2024-11-04 | |
| Assets | ||||||||
| Total Assets | 134.544 B | 135.367 B | 136.221 B | 134.711 B | 148.874 B | 141.937 B | 143.422 B | |
| Current Assets | 26.488 B | 28.852 B | 33.224 B | 33.002 B | 38.871 B | 33.816 B | 27.785 B | |
| Inventories | 3.833 B | 4.055 B | 3.981 B | 4.099 B | 4.245 B | 4.218 B | 4.450 B | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 11.000 M | 7.000 M | 3.000 M | 2.000 M | 2.000 M | 27.000 M | 28.000 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 6.711 B | 8.759 B | 13.287 B | 12.814 B | 18.067 B | 13.130 B | 7.257 B | |
| Total Non-current Assets | 257.000 M | 288.000 M | 275.000 M | 304.000 M | 305.000 M | 272.000 M | 267.000 M | |
| Property Plant Equipment | 4.931 B | 4.943 B | 4.934 B | 4.989 B | 4.980 B | 5.023 B | 5.141 B | |
| Other Assets | 103.125 B | 101.572 B | 98.063 B | 96.720 B | 105.023 B | 103.098 B | 110.496 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 134.544 B | 135.367 B | 136.221 B | 134.711 B | 148.874 B | 141.937 B | 143.422 B | |
| Total liabilities | 121.241 B | 122.469 B | 124.092 B | 124.314 B | 140.827 B | 135.116 B | 137.351 B | |
| Total current liabilities | 27.590 B | 32.239 B | 34.773 B | 37.841 B | 41.522 B | 41.915 B | 43.062 B | |
| Accounts Payable | 24.789 B | 27.036 B | 29.658 B | 30.650 B | 31.326 B | 29.329 B | 30.492 B | |
| Other liabilities | 32.249 B | 32.294 B | 31.644 B | 32.327 B | 32.778 B | 32.427 B | 33.031 B | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 59.292 B | 55.812 B | 55.631 B | 52.194 B | 63.805 B | 58.048 B | 58.509 B | |
| Other liabilities | 32.249 B | 32.294 B | 31.644 B | 32.327 B | 32.778 B | 32.427 B | 33.031 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 13.274 B | 12.866 B | 12.094 B | 10.360 B | 8.007 B | 6.778 B | 6.032 B | |
| Common stock | 19.637 B | 19.857 B | 20.039 B | 20.198 B | 20.674 B | 20.897 B | 21.178 B | |
| Retained earnings | 2.393 B | 1.789 B | 933.000 M | -1.000 B | -2.384 B | -3.768 B | -4.964 B |